Viking Therapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for VKTX, updated each market day.
VKTX AI Sentiment
AI sees no strong directional signal for Viking Therapeutics, Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Viking Therapeutics, Inc
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Sector
Exchange
Market Cap
$4,050,493,307
Cap Tier
Employees
53
Headquarters
SAN DIEGO, CA
Listed Since
April 29, 2015
VKTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VKTX Volatility
Viking Therapeutics, Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
